Literature DB >> 14572803

Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils.

Marguerite R Kelher1, Daniel R Ambruso, David J Elzi, Steven M Anderson, Andrew J Paterson, Gail W Thurman, Christopher C Silliman.   

Abstract

Chemoattractant priming and activation of PMNs results in changes in cytosolic Ca2+ concentration, tyrosine kinase activity, and gene expression. We hypothesize that the initial signaling for the activation of a 105kDa protein (Rel-1) requires Ca2+-dependent tyrosine phosphorylation. A rapid and time-dependent tyrosine phosphorylation of Rel-1 occurred following formyl-Met-Leu-Phe (fMLP) stimulation of human PMNs at concentrations that primed or activated the NADPH oxidase (10(-9) to 10(-6)M), becoming maximal after 30s. Pretreatment with pertussis toxin (Ptx) or tyrosine kinase inhibitors abrogated this phosphorylation and inhibited fMLP activation of the oxidase. The fMLP concentrations employed also caused a rapid increase in cytosolic Ca2+ but chelation negated the effects, including the cytosolic Ca2+ flux, oxidase activation, and the tyrosine phosphorylation of Rel-1. Conversely, chelation of extracellular Ca2+ decreased the fMLP-mediated Ca2+ flux, had no affect on the oxidase, and augmented tyrosine phosphorylation of Rel-1. Phosphorylation of Rel-1 was inhibited when PMNs were preincubated with a p38 MAP kinase (MAPK) inhibitor (SB203580). In addition, fMLP elicited rapid activation of p38 MAPK which was abrogated by chelation of cytosolic Ca2+. Thus, fMLP concentrations that prime or activate the oxidase cause a rapid Ca2+-dependent tyrosine phosphorylation of Rel-1 involving p38 MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572803     DOI: 10.1016/s0143-4160(03)00067-8

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  7 in total

1.  Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury.

Authors:  Samina Yasmin Khan; Marguerite R Kelher; Joanna M Heal; Neil Blumberg; Lynn K Boshkov; Richard Phipps; Kelly F Gettings; Nathan J McLaughlin; Christopher C Silliman
Journal:  Blood       Date:  2006-06-13       Impact factor: 22.113

2.  A comparison of different methods of red blood cell leukoreduction and additive solutions on the accumulation of neutrophil-priming activity during storage.

Authors:  Michele M Loi; Marguerite Kelher; Monika Dzieciatkowska; Kirk C Hansen; Anirban Banerjee; F Bernadette West; Crystal Stanley; Matthew Briel; Christopher C Silliman
Journal:  Transfusion       Date:  2018-09-01       Impact factor: 3.157

3.  Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Jun Tian; Andrei I Khlebnikov; Richard D Ye; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

4.  Tumor necrosis factor-alpha causes release of cytosolic interleukin-18 from human neutrophils.

Authors:  Christopher C Silliman; Marguerite R Kelher; Fabia Gamboni-Robertson; Christine Hamiel; Kelly M England; Charles A Dinarello; Travis H Wyman; Samina Y Khan; Nathan J D McLaughlin; Rachel S Bercovitz; Anirban Banerjee
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-11       Impact factor: 4.249

5.  Orai1 regulates intracellular calcium, arrest, and shape polarization during neutrophil recruitment in shear flow.

Authors:  Ulrich Y Schaff; Neha Dixit; Emily Procyk; Itsukyo Yamayoshi; Tiffany Tse; Scott I Simon
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

6.  Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.

Authors:  Isabel Vega-Carrascal; David A Bergin; Oliver J McElvaney; Cormac McCarthy; Nessa Banville; Kerstin Pohl; Mitsuomi Hirashima; Vijay K Kuchroo; Emer P Reeves; Noel G McElvaney
Journal:  J Immunol       Date:  2014-01-29       Impact factor: 5.422

7.  Mechanisms mediating the biologic activity of synthetic proline, glycine, and hydroxyproline polypeptides in human neutrophils.

Authors:  Barry Weinberger; Nazeeh Hanna; Jeffrey D Laskin; Diane E Heck; Carol R Gardner; Donald R Gerecke; Debra L Laskin
Journal:  Mediators Inflamm       Date:  2005-02-24       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.